A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults

Journal of Clinical Psychiatry

Volumn 67, Issue 4, 2006, Pages 611-619

  Weiss, Margaret ^a   Hechtman, Lily ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMPHETAMINE; PAROXETINE;

ADULT; AGED; ANGER; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; HAMILTON SCALE; HEADACHE; HUMAN; INSOMNIA; INTERVIEW; IRRITABILITY; MAJOR CLINICAL STUDY; MOOD DISORDER; POST HOC ANALYSIS; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEXUAL DYSFUNCTION; SIDE EFFECT;

EID: 33646768642     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n0412     Document Type: Article

References (44)

1. Kessler R. Prevalence of adult ADHD in the United States: results from the National Comorbidity Survey Replication (NCS-R). Psychol Med. In press
2. Shekim WO, Asarnow RF, Hess E, et al. A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry 1996;31:416-425
3. Murphy KR, Barkley RA. Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers. J Arten Disord 1996;1:147-162
4. Marks DJ, Newcorn JH, Halperin JM. Comorbidity in adults with attention-deficit/hyperactivity disorder. Ann N Y Acad Sci 2001;931:216-238
5. Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry 1998;59 (suppl 7):50-58
6. Wilens TE, Biederman J. Spencer TJ. Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med 2002;53:113-131
7. Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:1792-1798
8. Kessler RC, Adler LA, Barkley R. et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry 2005;57:1442-1451
9. Fones CS, Pollack MH, Susswein L, et al. History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder. J Affect Disord 2000;58:99-106
10. Safren SA, Lanka GD, Otto MW, et al. Prevalence of childhood ADHD among patients with generalized anxiety disorder and a comparison condition, social phobia [brief report]. Depress Anxiety 2001;13:190-191
11. Pliszka SR, Greenhill LL, Crismon ML, et al. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder, pt 2: tactics: attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2000;39:920-927
12. Weiss M, Trokenberg Hechtman L, Weiss G. ADHD in Adulthood: A Guide to Current Theory, Diagnosis and Treatment. Baltimore and London: Johns Hopkins University Press; 1999
13. Gammon GD, Brown TE. Fluoxetine augmentation of methylphenidate attention deficit and comorbid disorders. J Child Adolesc Psychopharmacol 1993;3:1-10
14. Spencer T, Wilens T, Biederman J, et al. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1995;52:434-443
15. Quist JF, Kennedy JL. Genetics of childhood disorders: XXIII: ADHD, pt 7: the serotonin system. J Am Acad Child Adolesc Psychiatry 2001;40:253-256
16. Rauch SL. Neuroimaging and attention-deficit/hyperactivity disorder in the 21st century: what to consider and how to proceed. Biol Psychiatry 57:1261-1262
17. Giedd JN, Blumenthal J, Molloy E, et al. Brain imaging of attention deficit/hyperactivity disorder. Ann N Y Acad Sci 2001;31:33-49
18. Hawi Z, Dring M, Kirley A, et al. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multicentre sample. Mol Psychiatry 2002;7:718-725
19. Zoroglu SS, Erdal ME, Alasehirli B, et al. Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder. Neuropsychobiology 2002;45:176-181
20. Nakamura K, Kurasawa M. Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam. Naunyn Schmiedebergs Arch Pharmacol 2000;361:521-528
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington. DC: American Psychiatric Press: 1994
22. First MB, Spitzer RL, Gibbon M. et al. Structured Clinical Interview for DSM-IV Axis I Disorders. Clinician Version (SCID-I). Washington, DC: American Psychiatric Press: 1997
23. Conners CK, Epstein JN, Johnson D. Conners Adult ADHD Diagnostic Interview for Adults. North Tonawanda, NY: Multihealth Systems: 2001
24. Faries DE, Yalcin I, Harder D, et al. Validation of the ADHD rating scale as a clinician administered and scored instrument. J Atten Disord 2001;5:39-47
25. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55
26. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
27. National Institute of Mental Health. CGI (Clinical Global Impression Scale)-NIMH. Psychopharmacol Bull 1985;21:839-843
28. Spencer T, Biederman J, Wilens T, et al. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2005;57:456-463
29. Cohen-Zion M, Ancoli-Israel S. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies. Sleep Med Rev 2004;8:379-402
30. Agranat-Meged AN, Deitcher C, Goldzweig G, et al. Childhood obesity and attention deficit/hyperactivity disorder: a newly described comorbidity in obese hospitalized children. Int J Eat Disord 2005;37:357-359
31. Altfas JR. Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry 2002;2:9
32. Holtkamp K, Konrad K, Muller B, et al. Overweight and obesity in children with attention-deficit/hyperactivity disorder. Int J Obes Relat Metab Disord 2004;28:685-689
33. Levitan RD, Masellis M, Lam RW, et al. Childhood inattention and dysphoria and adult obesity associated with the dopamine D4 receptor gene in overeating women with seasonal affective disorder. Neuropsychopharmacology 2004;29:179-186
34. Reimherr FW, Marchant BK, Strong RE, et al. Emotional dysregulation in adult ADHD and response to atomoxetine. Biol Psychiatry 2005;58:125-131
35. Bagby RM, Ryder AG, Schuller DR, et al. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 2004;161:2163-2177
36. Zimmerman M, Posternak MA, Chelminski I. Is it time to replace the Hamilton Depression Rating Scale as the primary outcome measure in treatment studies of depression? J Clin Psychopharmacol 2005;25:105-110
37. Greenhill LL, Pliszka S, Dulcan MK, et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2002;41:26S-49S
38. Carlson GA, Mick E. Drug-induced disinhibition in psychiatrically hospitalized children. J Child Adolesc Psychopharmacol 2003;13:153-163
39. Go FS, Malley EE, Birmaher B, et al. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 1998;8:73-80
40. Hoehn-Saric R, Harris GJ, Pearlson GD, et al. A fluoxetine-induced frontal lobe syndrome in an obsessive compulsive patient. J Clin Psychiatry 1991;52:131-133
41. Hoehn-Saric R, Lipsey JR, McLeod DR. Apathy and indifference in patients on fluvoxamine and fluoxetine. J Clin Psychopharmacol 1990;10:343-345
42. Weiss M, Walkup J, Garland EJ. Stimulants and SSRIs. Child Adolesc Psychopharmacol News 1997;2:11-12
43. Miller AR, Lalonde CE, McGrail KM. Children's persistence with methylphenidate therapy: a population-based study. Can J Psychiatry 2004;49:761-768
44. Bussing R, Zima BT, Mason D, et al. Use and persistence of pharmacotherapy for elementary school students with attention-deficit/ hyperactivity disorder. J Child Adolesc Psychopharmacol 2005;15:78-87